Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 11 studies | 27% ± 9% | |
epithelial cell | 5 studies | 32% ± 16% | |
ciliated cell | 5 studies | 26% ± 5% | |
fibroblast | 4 studies | 22% ± 5% | |
pancreatic A cell | 3 studies | 31% ± 7% | |
type B pancreatic cell | 3 studies | 34% ± 5% | |
dendritic cell | 3 studies | 25% ± 5% | |
basal cell | 3 studies | 29% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
pancreas | 3 studies | 31% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1076.32 | 328 / 328 | 100% | 23.40 | 178 / 178 |
stomach | 100% | 1282.82 | 359 / 359 | 100% | 26.30 | 286 / 286 |
lung | 100% | 1168.15 | 578 / 578 | 100% | 30.33 | 1154 / 1155 |
ovary | 100% | 1284.25 | 180 / 180 | 100% | 28.10 | 428 / 430 |
brain | 99% | 887.05 | 2627 / 2642 | 100% | 37.45 | 705 / 705 |
skin | 100% | 978.50 | 1806 / 1809 | 100% | 33.39 | 470 / 472 |
thymus | 100% | 1497.20 | 653 / 653 | 99% | 29.24 | 600 / 605 |
prostate | 100% | 1362.04 | 245 / 245 | 99% | 25.62 | 497 / 502 |
kidney | 100% | 1417.89 | 89 / 89 | 99% | 29.23 | 892 / 901 |
intestine | 100% | 1478.55 | 966 / 966 | 99% | 28.60 | 521 / 527 |
breast | 100% | 1242.15 | 459 / 459 | 99% | 26.46 | 1102 / 1118 |
bladder | 100% | 1412.05 | 21 / 21 | 98% | 26.14 | 496 / 504 |
esophagus | 100% | 1172.44 | 1444 / 1445 | 98% | 21.10 | 180 / 183 |
uterus | 100% | 1251.94 | 170 / 170 | 96% | 21.16 | 440 / 459 |
adrenal gland | 100% | 1492.76 | 258 / 258 | 93% | 19.24 | 215 / 230 |
liver | 100% | 832.46 | 226 / 226 | 92% | 16.66 | 372 / 406 |
adipose | 100% | 1206.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1336.90 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 37.21 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.95 | 29 / 29 |
muscle | 100% | 1462.68 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 915.00 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.19 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 15.82 | 44 / 45 |
heart | 94% | 867.21 | 811 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 588.75 | 853 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0018230 | Biological process | peptidyl-L-cysteine S-palmitoylation |
GO_0006612 | Biological process | protein targeting to membrane |
GO_0045089 | Biological process | positive regulation of innate immune response |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0016409 | Molecular function | palmitoyltransferase activity |
GO_0019706 | Molecular function | protein-cysteine S-palmitoyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ZDHHC4 |
Protein name | Palmitoyltransferase ZDHHC4 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 4) (DHHC-4) (Zinc finger protein 374) Zinc finger DHHC-type palmitoyltransferase 4 |
Synonyms | UNQ5787/PRO19576 ZNF374 DC1 |
Description | FUNCTION: Palmitoyltransferase that could catalyze the addition of palmitate onto protein substrates including the D(2) dopamine receptor DRD2. . |
Accessions | ENST00000335965.11 ENST00000396709.5 ENST00000405731.7 C9J5I9 ENST00000396713.6 ENST00000483589.5 Q9NPG8 ENST00000396706.2 ENST00000396707.6 |